Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 2.59 CAD Market Closed
Market Cap: 998.2m CAD

CRON's latest stock split occurred on Dec 17, 2014

The company executed a 1-for-7 stock split, meaning that for every 7 shares held, investors received 1 new share.

The adjusted shares began trading on Dec 17, 2014. This was the only stock split in CRON's history.

Last Splits:
Dec 17, 2014
1-for-7
Pre-Split Price
N/A
Post-Split Price
0.8
Before
After
Last Splits:
Dec 17, 2014
1-for-7

Cronos Group Inc
Stock Splits History

CRON Stock Splits Timeline
Dec 17, 2014
Dec 17, 2014
Split 1-for-7
/0.14285714285714
Pre-Split Price
N/A
Post-Split Price
0.8
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jun 17, 2025
Ningbo Dechang Electrical Machinery Made Co Ltd
SSE:605555
1-for-1
x1
16.0615 15.7115 CNY 15.55 15.55 CNY
Jun 17, 2025
Search Minerals Inc
OTC:SHCMF
1-for-10
/10
0.251 0.251 USD 0.251 0.251 USD
Jun 17, 2025
Sensei Biotherapeutics Inc
F:407
1-for-20
/20
0.26 5.2 EUR 5.2 5.2 EUR
Jun 17, 2025
H
Hunan Junxin Environmental Protection Co Ltd
SZSE:301109
1-for-1
x1
22.91 15.4643 CNY 15.24 15.24 CNY
Jun 17, 2025
S
Shenzhen Urban Transport Planning Center Co Ltd
SZSE:301091
1-for-1
x1
36.67 28.1567 CNY 27.66 27.66 CNY
Load More

Cronos Group Inc
Glance View

Market Cap
998.2m CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.67 CAD
Overvaluation 36%
Intrinsic Value
Price
Back to Top